Total amount raised
$301 Millions
Latest funding date
9/1/2024
Location
Viome has successfully raised significant funding through multiple rounds, including a recent Series D round where it secured $25 million. The company is backed by notable investors such as Marc Benioff and Khosla Ventures.
Keep reading to explore the intricacies of Viome's fundraising journey and the investors backing this innovative platform.
What Is Viome?
Viome, founded on October 1, 2016, is based in Bellevue, Washington. The company was established by John Pinelli and Naveen Jain.
Viome specializes in providing comprehensive health insights to help individuals track their gut microbiome, mitochondrial health, cellular health, and biological age. Their services include personalized recommendations based on various health tests.
With a team of 101-250 employees, Viome leverages artificial intelligence to offer at-home microbiome health tests and custom-formulated supplements, aiming to improve overall health and longevity.
How Much Funding Has Viome Raised?
- Series A
- Amount Raised: $15M
- Date: July 2017
- Lead Investors: Khosla Ventures
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To develop and launch their initial health insights platform.
- Series B
- Amount Raised: $5.5M
- Date: July 2018
- Lead Investors: Better Health Group
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand their product offerings and market reach.
- Series B
- Amount Raised: $25M
- Date: April 2019
- Lead Investors: Marc Benioff
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To further develop their AI-driven health insights and expand their customer base.
- Debt Financing
- Amount Raised: $3M
- Date: February 2021
- Lead Investors: -
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support ongoing operational expenses and product development.
- Series C
- Amount Raised: $54M
- Date: November 2021
- Lead Investors: Ocgrow Ventures
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To scale their operations and enhance their product offerings.
- Debt Financing
- Amount Raised: $20M
- Date: January 2022
- Lead Investors: -
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support the company's growth and operational needs.
- Series C
- Amount Raised: $67M
- Date: October 2022
- Lead Investors: Bold Capital Partners
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand their testing portfolio and enter new markets.
- Series C
- Amount Raised: $86.5M
- Date: August 2023
- Lead Investors: Bold Capital Partners, Khosla Ventures
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support the development of new diagnostic tests and expand retail sales.
- Series D
- Amount Raised: $25M
- Date: September 2024
- Lead Investors: Khosla Ventures, Bold Capital WRG Ventures, Marc Benioff
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To launch a diagnostic division and hire Kal Raman as COO.
Viome has raised a total of $301M. The current valuation is not publicly disclosed.
Key Investors
- Marc Benioff
- Details: Marc Benioff is the CEO of Salesforce and a prominent tech investor. He is known for his philanthropic efforts and investments in innovative companies.
- Investment Focus Areas: Technology, healthcare, social impact.
- Notable Investments: Salesforce, Twitter, Planet Labs.
- Khosla Ventures
- Details: Khosla Ventures is a venture capital firm founded by Vinod Khosla. The firm focuses on impactful technology investments.
- Investment Focus Areas: Technology, healthcare, sustainability, transformative sectors.
- Notable Investments: Square, DoorDash, Impossible Foods, Guardant Health.
- Bold Capital Partners
- Details: Bold Capital Partners invests in transformative technologies. The firm aims to support companies that have the potential to change industries.
- Investment Focus Areas: Disruptive technologies, healthcare, life sciences.
- Notable Investments: SpaceX, Virgin Hyperloop, Vicarious Surgical.
- WRG Ventures
- Details: WRG Ventures is a venture capital firm that focuses on early-stage technology and healthcare companies. Specific details about the firm are limited.
- Investment Focus Areas: Early-stage technology, healthcare.
- Notable Investments: Information not provided.
- Ocgrow Ventures
- Details: Ocgrow Ventures is a venture capital firm that invests in high-growth technology companies. The firm is known for its strategic investments in innovative sectors.
- Investment Focus Areas: Technology, real estate, healthcare.
- Notable Investments: Information not provided.
What's Next for Viome?
Viome is poised to make significant strides with the launch of its new diagnostic division, aiming to revolutionize early disease detection and preventative healthcare. The company plans to expand its testing portfolio, including new diagnostic tests for chronic diseases, cancer, and aging. This expansion taps into a vast market, as only a small percentage of Americans currently undergo routine preventive screenings.
Future fundraising opportunities appear promising, with continued support from key investors like Khosla Ventures and Marc Benioff. As Viome demonstrates success in launching new tests and expanding its market presence, it is likely to attract additional investment. However, the company will need to navigate challenges such as ensuring the accuracy of new tests and competing in a rapidly growing market.
Use Clay to Get Funding Data
Sales professionals, take your strategy to the next level by leveraging Clay’s platform to access comprehensive fundraising data on companies like Viome and gather other critical business insights.
Sign up for free on Clay and start making data-driven decisions today.
